Press release

Press release

We have issued a press release announcing the start of a multicenter specified clinical study aimed at developing and obtaining approval for a smartphone app-based software medical device that supports dry eye diagnosis using smartphones.

We have issued a press release announcing the start of a multicenter specified clinical study aimed at developing and obtaining approval for a smartphone app-based software medical device that supports dry eye diagnosis using smartphones.

We have issued a press release announcing the start of a multicenter specified clinical study aimed at developing and obtaining approval for a smartphone app-based software medical device that supports dry eye diagnosis using smartphones.

A research group led by Associate Professor Masahiro Yamaguchi and Associate Professor Takenori Inomata of the Department of Ophthalmology, Juntendo University Faculty of Medicine, together with InnoJin Inc., a venture company originating from Juntendo University, will begin a multicenter joint specified clinical study in March 2023 to evaluate the diagnostic performance for dry eye using a smartphone application (DEA01) that assists in dry eye diagnosis.

http://prtimes.jp/main/html/rd/p/000000009.000088821.html

https://www.juntendo.ac.jp/news/13098.html